Healthcare IT: Changing the Way You Get Your Medical Care...!!

 

The healthcare system in the developed countries is moving from fee-for-service to value-based payments. Value-based programs reward health care providers with incentive payments for the quality of care delivered to patients. Value-based care majorly focuses on healthcare outcomes and not procedures. It pushes healthcare systems to deliver higher-quality care at lower costs. The shift to value-based care is not just a shift in economics, but it is also a shift in the kinds of technologies required to deliver such economic benefits. The move to value-based care includes a move to reimbursement based on "episodes of care," which necessitate changes to billing, data collection, and reimbursement rules, along with the technologies that support those models.

Accountable Care Organization (ACOs) and value-based payment models are spurring the trend towards payer-provider mergers, partnerships, and joint ventures, to address fragmented healthcare delivery, emphasize patient-centered care, and promote care coordination, thereby aligning the goals and incentives among payers, providers, and patients. This evolution towards value-based reimbursement benefits all three stakeholders of the healthcare industry, including the patient, healthcare providers, and payers. Value-based reimbursement encourages healthcare providers to deliver the best care at the lowest cost. In turn, patients receive a higher quality of care at a better value.

Today, various healthcare IT solutions, such as EHRs, population health management solutions, revenue cycle management solutions, quality reporting solutions, healthcare analytics solutions, and accountable care solutions are helping healthcare institutions to provide quality care and maintain their financial health. Such benefits of healthcare IT solutions are driving the overall adoption of these solutions across the healthcare ecosystem, thereby propelling the growth of the overall healthcare IT solutions market.

The healthcare IT market is expected to grow at a CAGR of 13.8% from 2019 to reach $511.06 billion by 2027. Increasing awareness on the value of digital health, government mandates and financial incentives for adoption of HCIT solutions, shift towards value-based care, rising use of big data in healthcare management, high return on IT investment in the healthcare industry, and rising incidence of chronic diseases are some of the key factors supporting the overall growth of the global healthcare IT market. However, high installation & maintenance cost and lack of required IT infrastructure in developing countries are restraining the market growth to a certain extent.

Download Free Sample Report Now @  https://www.meticulousresearch.com/download-sample-report/cp_id=5084?utm_source=PDF&utm_medium=Social&utm_campaign=Product&utm_content=24-03-2022

For the purpose of this study, the global healthcare IT solutions market is broadly segmented by product, component, deployment mode, end user, and geography.

Based on product type, the overall HCIT market is categorized into healthcare providers solutions, healthcare payers solutions, and healthcare IT outsourcing services market. In 2019, the healthcare providers solutions segment accounted for the largest share of the overall healthcare IT market. This large share can be attributed increasing demand for integrated healthcare solutions, growing focus on patient safety & care, rising investments in development of healthcare infrastructure in emerging countries, increasing demand for quality healthcare, increasing number of government initiatives and regulatory mandates on implementing eHealth solutions, and rising awareness about electronic health records (EHRs). Growing geriatric population and thereby increase in prevalence of chronic diseases and patient workload on healthcare systems across the globe are also driving adoption of digitization solutions among healthcare providers. In addition, Affordable Care Act in the U.S. and growing demand to manage large patient data further supports the growth of HCIT solutions market for healthcare providers across globe.

Based on type, healthcare provider solutions market is further segmented into clinical healthcare IT solutions and non-clinical healthcare IT solutions. Clinical HCIT solutions segment accounted for the largest share of the  healthcare provider solutions market in 2019, owing to factors such as growing focus on patient safety & care, increasing demand for integrated health IT solutions among healthcare providers, transition of healthcare industry towards value based care, and increasing regulatory requirements for healthcare providers to incorporate digitization solutions. However, non-clinical HCIT solutions segment is expected to grow at the fastest CAGR during the forecast period. Increasing demand for achieving operational and administrative efficiencies in healthcare delivery in order to lower the cost of healthcare and growing regulatory requirements for achieving reimbursement are the key factors driving the growth of the non-clinical healthcare IT solutions market.

Speak to our Analysts to Understand the Impact of COVID-19 on Your Business:  https://www.meticulousresearch.com/speak-to-analyst/cp_id=5084?utm_source=PDF&utm_medium=Social&utm_campaign=Product&utm_content=24-03-2022

Based on type, the clinical healthcare IT solutions market is further segmented into number of areas, including EHR/EMR, CDSS, CPOE, PACS/VNA, E-Prescribing solutions, radiology information systems, radiation dose management solutions, medical image analysis systems, care management solutions, mhealth solutions, telehealth solutions, practice management systems, and population health management systems, among others. In 2019, EHR solutions accounted for the largest share of the overall clinical healthcare IT solutions market. The large share of EHR solutions is mainly attributed to growing efforts across the globe to digitize patient records and increasing number of government initiatives and policies to implement eHealth strategies. EHR forms the basis of digitization in the healthcare industry, which is one of the key factors driving large adoption of EHR solutions across the globe. However, considering growing consumerism in the healthcare industry, the mHealth solutions market segment is expected to register the fastest CAGR during the forecast period of 2019 to 2027.

The non-clinical healthcare IT solutions market primarily comprises various software solutions including pharmacy information systems, asset management solutions, workforce management solutions, revenue cycle management solutions, medical document management solutions, healthcare analytics solutions, supply chain management solutions, medication management solutions, healthcare quality management solutions, and interoperability solutions. In 2019, the healthcare analytics segment accounted for the largest share of the overall non-clinical healthcare IT solutions market. Growing pressure on healthcare providers to enhance the quality of care and curtail the soaring cost of healthcare are some of the key factors driving the growth of the overall healthcare analytics market.

The payer solutions market segment mainly comprises, claims management solutions, population health management solutions, pharmacy audit and analysis solutions, payment management solutions, member eligibility management solutions, fraud and risk analytics solutions, and provider network management solutions, among others. In 2019, the claims management solutions segment accounted for the largest share of the overall healthcare payer solutions market. The growing volume of claim submissions and transactions processed every day, increasing number of hospital visits or utilization of number of healthcare services by patients are some of the key factors driving the adoption of claims management solutions.

Quick Buy – Healthcare IT Market Research Report:  https://www.meticulousresearch.com/Checkout/24989313?utm_source=PDF&utm_medium=Social&utm_campaign=Product&utm_content=24-03-2022

Based on delivery model, the web/cloud-based healthcare IT solutions accounted for the largest share of the overall healthcare IT market in 2019. The benefits of web/cloud-based solutions such as on-demand self-serving deployment model, lower upfront cost of deployment, no maintenance cost, lower storage cost, excessive storage flexibility, and enhanced scalability are some of the key factors driving the adoption of cloud-based HCIT solutions among healthcare payers and providers. In addition, greater security in private clouds and automated updating features of web and cloud solutions are further expected to support the growth of this market during the forecast period.

Based on component, the overall healthcare IT market is broadly segmented into hardware, software, and services. The services segment accounted for the largest share of the healthcare IT market in 2019. The shift towards cloud-based services, increasing need to reduce healthcare costs, and increasing adoption of digital solutions across healthcare organizations are some of the key factors driving the growth of the services market during the forecast period. In addition, the growing need to reduce administrative overheads of the healthcare industry, enhance productivity of healthcare operations, and rising demand for easy access to affordable care further supports the growth of this market.

Based on end user, the overall healthcare IT market is broadly segmented into healthcare providers and healthcare payers. The healthcare provider segment accounted for the largest share of the overall HCIT market in 2019. The largest share of this segment is primarily attributed to the rising patient volume, growing healthcare spending by the countries across globe, rising awareness about electronic health records (EHRs), growing geriatric population, and increasing adoption of healthcare IT solutions by healthcare providers.

Based on geography, the global healthcare IT market is categorized into five major regions, namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa with a country level analysis of this market in each region. In 2019, North America accounted for the largest share of the global healthcare IT market, followed by Europe and Asia-Pacific. Growing adoption of various healthcare IT solutions by healthcare providers in order to meet the heightened regulatory requirements for patient care and safety, increasing need to curtail the soaring healthcare costs, growing need to improve the quality of healthcare while maintaining the operational efficiency of healthcare organizations, and presence of leading HCIT vendors in the region, are some of the major factors driving the growth of the HCIT market in North America.

Some of the key players operating in global Healthcare IT market are McKesson Corporation (U.S.), Optum Health (U.S.), International Business Machine Corporation (IBM) (U.S.), Allscripts Healthcare Solutions, Inc. (U.S.), athenahealth, Inc. (U.S.), Epic Systems Corporation (U.S.), Dell Technologies Inc. (U.S.), GE Healthcare (U.S.), Cerner Corporation (U.S.), Oracle Corporation (U.S.), Cognizant Technology Solutions Corporation (U.S.), Nuance Communications, Inc. (U.S.), eClinicalWorks (U.S.) NextGen Healthcare, Inc. (U.S.), Computer Programs and Systems, Inc. (CPSI) (U.S.), Conifer Health Solutions, LLC. (U.S.), 3M Company (U.S.), Koninklijke Philips N.V. (The Netherlands), and Infor, Inc. (U.S.) among others.

Top 10 Companies in Healthcare IT Market

Scope of the report:

Healthcare IT Market, by Product                                       

• Healthcare provider solutions
• Clinical Healthcare IT Solutions

§   

• Electronic Health Record (EHR)       
• PACS & VNA
• Computerized Physician Order Entry
• Clinical Decision Support System (CDSS)
• E-Prescribing system
• Patient Engagement Solutions
• Radiology Information Systems (RIS)
• Radiation Dose Management Solutions
• Specialty Information Management Systems
• Medical Image Analysis Systems
• Population Health Management Solutions
• Care Management Systems
• Patient Registry Software
• Laboratory Information Systems
• mheath Solutions
• Telemedicine
• HCIT Integration Systems
• Infection Surveillance Solutions
• Practice Management Systems
• Non-Clinical Healthcare IT Solutions

§   

• Pharmacy Information Systems
• Healthcare Asset Management Solutions
• Healthcare Workforce Management Solutions
• Revenue Cycle Management Solutions
• Front-End RCM Solutions
• Mid-RCM Solutions
• Back-End RCM
• Medical Document Management Solutions
• Healthcare Information Exchanges
• Supply Chain Management Solutions
• Healthcare Analytics
• Clinical Analytics
• Financial Analytics
• Operational and Administrative Analytics
• Customer Relationship Management Solutions
• Medication Management Solutions
• Electronic Medication Administration Software
• Barcode Medication Administration Systems
• Medication Inventory Management Systems
• Medication Assurance Systems
• Healthcare Quality Management Solutions
• Healthcare Interoperability Solutions
• Financial Management Systems (Billing & Accounting)
• Healthcare payer solutions
• Claims Management Solutions
• Customer Relationship Management Solutions
• Fraud Analytics Solutions
• Provider Network Management Solutions
• Pharmacy Audit and Analysis Solutions
• Member Eligibility Management Solutions
• Population Health Management Solutions
• Payment Management Solutions
• Healthcare IT Outsourcing Services 
• Provider HCIT Outsourcing services
• Revenue Cycle Management Services
• EMR/Medical Document Management Services
• Laboratory Information Management Services
• Other Provider HCIT Outsourcing Services
• Payer HCIT Outsourcing services   
• Claims Management Services
• Provider Network Management Services
• Billing & Accounts Management Services
• Fraud Analytics Services
• Other Payer HCIT Outsourcing Services
• Operational HCIT Outsourcing Services    
• Business Process Management Services
• Supply Chain Management Services
• Other Operational IT Outsourcing Services
• IT Infrastructure Management Services

Global Healthcare IT Market, by Delivery Mode                                      

• Wed & Cloud-Based
• On-premises

Global Healthcare IT Market, by Component                                           

• Services
• Software
• Hardware

Global Healthcare IT Market, by End User                              

• Healthcare Providers
• Hospitals
• Ambulatory Centers
• Home healthcare & Assisted Living Centers
• Diagnostic Centers
• Pharmacies
• Healthcare Payers
• Private payers
• Public payers

Global Healthcare IT Market, by Geography                                            

• North America                                          
• U.S.                           
• Canada                     
• Europe                                         
• U.K.                              
• Germany                 
• France                       
• Italy                            
• Spain                
• Benelux                    
• Nordics
• Rest of Europe
• Asia-Pacific                                 
• China                         
• Japan                         
• India                          
• South Korea                           
• Australia                   
• Rest of Asia-Pacific
• Latin America 
• Brazil
• Mexico
• Rest of Latin America (RoLA)
• Middle East and Africa (MENA) 

Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5084?utm_source=PDF&utm_medium=Social&utm_campaign=Product&utm_content=24-03-2022

MICROENCAPSULATION MARKET WORTH $17.31 BILLION BY 2027

Meticulous Research® – leading global market research company, published a research report titled “Microencapsulation Market by Coating Material (Polysaccharides, Proteins), Technology [Physico-Mechanical (Spray Drying, Coextrusion); Physico-Chemical; Chemical], Application (Pharmaceutical, Food), Core Material, and Core Form - Global Forecast to 2027.”

 

According to this latest publication from Meticulous Research®, the microencapsulation market is expected to grow at a CAGR of 11.7% from 2020 to 2027 to reach $17.31 billion by 2027. The growth of the microencapsulation market is mainly attributed to the growing demand for pharmaceutical & agrochemical products, rising demand for functional food products, expanding cosmetic industry, growing demand for microencapsulated fragrances due to their wide applications across the home care and personal care industries, and rising R&D investment for improving process efficiency. However, the high production cost associated with the microencapsulation process and stringent regulatory requirements are factors expected to restrain the future growth of this market to some extent.

 

The microencapsulation market report presents historical market data in terms of value (2018 and 2019), estimated current data (2020), and forecasts for 2027. The market has been segmented into core material [pharmaceutical & healthcare drugs; food, feed, and nutraceuticals (vitamins and minerals, enzymes, organic acids, prebiotics and probiotics, sweeteners, flavors and colors, amino acids and proteins, essential oils, other core materials); fragrances; agriculture inputs; phase change material; and other core material]; core form (liquid, solid, gas); coating material (polysaccharides, polymers, proteins, lipids & waxes, gums & resins, and others); technology/method [physico-mechanical methods (spray drying, fluidized bed spray coating, coextrusion, spray chilling or congealing, other physico-mechanical methods); physico-chemical methods (coacervation or phase separation methods and other physico-chemical methods); chemical methods (in-situ polymerization and interfacial polymerization); and other microencapsulation methods]; application/industrial sector (pharmaceutical, home and personal care, food, feed, and nutraceuticals, agrochemical and others; and geography. The study also evaluates industry competitors and analyses the market at a country level.

 

Download Research Report @ https://www.meticulousresearch.com/download-sample-report/cp_id=3294?utm_source=Blog&utm_medium=Social&utm_campaign=Product&utm_content=22-03-2022

 

Based on the core material, in 2020, the pharmaceutical & healthcare drugs segment is estimated to account for the largest share of the microencapsulation market. The cost-effectiveness as compared to other technologies, particle size reduction for high solubility, and controlled and sustained release of drugs are the major factors responsible for the largest share of this segment.

 

Based on core form, the liquid form segment is expected to register the fastest CAGR during the forecast period. Liquid core active substances involve oils, pigments, solvents, perfumes, and agrochemicals, among others. These materials contain the additional property of getting dissolved and dispersed.

 

Based on the coating material, the polysaccharides segment is estimated to account for the largest share of the market in 2020. Polysaccharides can be obtained from abundant renewable sources and are typically nontoxic, making them valuable for food and pharmaceutical formulations. Further, starch is the most consumed polysaccharide in the human diet as it is generally regarded as safe material and is therefore listed in the GRAS list of the U.S. Food and Drug Administration.

 

Based on the technology/method, the physico-mechanical methods segment is estimated to account for the largest share of the market in 2020. The large share of this segment is mainly attributed to the wide range of benefits offered by these technologies, including high production capacity, high recovery efficiency, cost-effectiveness, and simplicity of the process with safety.

 

Request Free Research Sample @ https://www.meticulousresearch.com/request-sample-report/cp_id=3294?utm_source=Blog&utm_medium=Social&utm_campaign=Product&utm_content=22-03-2022

 

Based on application, the pharmaceutical segment is estimated to command the largest share of the microencapsulation market in 2020. The key factors driving the demand for microencapsulation for the pharmaceutical products is its unique properties, such as protection of the drug from the environment, stabilization of sensitive drug substances, elimination of incompatibilities or masking of unpleasant taste, conversion of liquid drugs in a free-flowing powder, and prevention of vaporization of many volatile drugs. Further, the growing demand for microencapsulated biomolecules in the pharmaceutical industry fuels the growth of the microencapsulation market for pharmaceutical applications.

 

This research report analyzes major geographies and provides a comprehensive analysis for North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and RoE), Asia-Pacific (China, India, Japan, and RoAPAC), Latin America, and the Middle East & Africa. North America region is estimated to hold the largest share of the microencapsulation market in 2020, followed by Europe and Asia-Pacific. However, the Asia-Pacific market is expected to register the fastest growth during the forecast period of 2020-2027. The rapid growth of this regional market is mainly attributed to the accelerated economic growth of many countries in this region, growing industrialization, and increasing awareness about functional products.

 

The microencapsulation market space is characterized by a moderately competitive scenario due to the presence of many large- and small-sized regional and local players. The key players operating in the microencapsulation market are Givaudan S.A. (Switzerland), International Flavors & Fragrances, Inc.(U.S.), Encapsys, LLC (U.S.), Reed Pacific Pty Limited (Australia), Firmenich Incorporated (Switzerland), Symrise AG (Germany), Ingredion Incorporated (U.S.), MikroCaps d.o.o (Slovenia), Koehler Innovative Solutions (Germany), Koninklijke DSM N.V. (Netherlands), Sensient Technologies (U.S.), Evonik Industries AG (Germany), and Micropore Technologies Limited (U.K.), among others.

TOP 10 COMPANIES IN MICROENCAPSULATION MARKET

Key Questions Answered in the Report-

• What is the current value of revenue generated by the microencapsulation market?
• At what rate is the demand for the microencapsulation market is projected to grow over the next 5-7 years?
• What is the historical market size and growth rate for the microencapsulation market?
• What are the major factors impacting the growth of this market at the regional and country levels? What are the major opportunities for existing players and new entrants in the market?
• What impact does the current COVID-19 pandemic have on the microencapsulation market?
• Which segments in terms of the core material, core form, coating material, technology/methods, and application create major traction for the vendors in this market?
• What are the key geographical trends in this market? Which countries are expected to offer significant growth opportunities for the vendors operating in the microencapsulation market?
• Who are the major players in the microencapsulation market? What are their specific product/technology offerings in this market space?
• What recent developments have taken place in the microencapsulation market? What impact have these strategic developments created on the microencapsulation market?

 

Contact Us:

Meticulous Research®

Email- sales@meticulousresearch.com

Contact Sales- +1-646-781-8004

Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

Electric Vehicle Charging Stations: Trend, Demand and Industry Analysis

Meticulous Research®— a leading global market research company, published a research report titled “Electric Vehicle Charging Stations Market by Charging Type (Level 1, Level 2, DCFC), Connection Type (Pantograph, Connector, Wireless), Component (Hardware, Software, Services), Mounting Type (Wall, Pedestal, and Ceiling) Vehicle Type, End-user, and Geography -  Global Forecast to 2028”.

 

The electric vehicle charging stations market is expected to grow at a CAGR of 26.4% by value from 2021 to reach $103.6 billion by 2028. By volume, this market is expected to grow at a CAGR of 31.1% from 2021 to reach 11.6 million units by 2028. This market is majorly driven by factors such as government initiatives to drive the adoption of electric vehicles and associated infrastructure, rising demand for electric vehicle fast-charging infrastructure, increasing prevalence of range anxiety, and increasing deployment of EVs by shared mobility operators. Moreover, increasing R&D in V2G technology, increasing adoption of electric mobility in emerging economies, and growing deployment of charging stations by retail MNCs provide significant opportunities in this market. However, the high initial cost of installation obstructs the growth of this market to some extent. High electricity tariffs in developing economies is a major challenge for the growth of the electric vehicle charging stations market.

 

The market is segmented based on charging type, connection type, vehicle type, mounting type, component, end user, and geography. The study also evaluates industry competitors and analyzes the market at the country level.

 

Based on charging type, the electric vehicle charging stations market is mainly segmented into Level 2, Level1, and DC fast charging. The Level 2 segment accounted for the largest share of the electric vehicle charging stations market in 2020 by both value and volume. The large share of this segment is mainly attributed to government funding and incentives for the installation of Level 2 charging stations, lower installation cost compared to DC fast-charging stations, and greater efficiency in terms of less charging time than Level 1 charging stations. However, the DC fast charging segment is expected to witness significant growth by both value and volume, as DC fast chargers provide faster charging as compared to Level 1 & Level 2 charging stations.

 

Based on connection type, the electric vehicle charging stations market is segmented into pantograph, connectors, and wireless EV charging. The connectors segment accounted for the largest share of the electric vehicle charging stations market in 2020. The large share of this segment is mainly attributed to government and automakers initiatives to expand the DC fast-charging station infrastructure, increasing investment by stakeholders of electric mobility in emerging economies for developing EV charging infrastructure, and increasing collaboration between electric vehicle charging station providers and utility companies and fuel station operators to deploy charging stations for electric vehicles. However, the wireless EV charging segment is expected to grow at the highest CAGR during the forecast period. The rapid growth of this segment is mainly attributed to the standardization of wireless EV charging systems leading to increased R&D and pilot projects for deploying wireless EV charging stations.

 

Based on component, the electric vehicle charging stations market is segmented into hardware, software, and services. The hardware segment accounted for the largest share of the electric vehicle charging stations market in 2020. The large share of this segment is mainly attributed to infrastructural developments for supporting the transition to electric mobility, increasing demand for EV charging stations in developing and developed economies, and attractive fiscal and non-fiscal incentive plans for setting up manufacturing units of EV charging stations and related components. However, the software segment is expected to grow at the highest CAGR during the forecast period. The rapid growth of this segment is mainly attributed to increasing software adoption to overcome the optimum power challenges and optimize charging station operation.

 

Request Sample Report with full Toc @ https://www.meticulousresearch.com/request-sample-report/cp_id=5078?utm_source=Article&utm_medium=Social&utm_campaign=Product&utm_content=10-02-2022

 

 

Based on mounting type, the electric vehicle charging stations market is segmented into wall mount, pedestal mount, and ceiling mount. The wall mount segment accounted for the largest share of the electric vehicle charging stations market in 2020. The large share of this segment is mainly attributed to the cost-effectiveness of the wall mount chargers, easy installation process, and various fiscal and non-fiscal incentives to private property owners and management companies for the development of EV charging infrastructure. However, the pedestal mount segment is expected to grow at the highest CAGR during the forecast period. The rapid growth of this segment is mainly attributed to the increasing deployment of pedestal-mounted EV chargers by real estate property owners and managers.

 

Based on vehicle type, the electric vehicle charging stations market is segmented into passenger cars, light commercial vehicles, heavy commercial vehicles, and two-wheelers & scooters. The passenger cars segment accounted for the largest share of the electric vehicle charging stations market in 2020. The large share of this segment is mainly attributed to the increasing favorable government policies and subsidies for promoting the adoption of electric vehicles, growing awareness regarding the role of electric vehicles in reducing emissions, increasing fuel prices, and proactive participation by automotive OEMs in producing electric passenger vehicles. However, the light commercial vehicle segment is expected to grow at the highest CAGR during the forecast period. The rapid growth of this segment is mainly attributed to stringent government rules and regulations towards vehicle emissions.

 

Based on end user, the electric vehicle charging stations market is segmented into commercial and residential EV charging stations. The commercial EV charging stations segment accounted for the largest share of the electric vehicle charging stations market in 2020. The large share of this segment is mainly attributed to the growing number of EV charging stations in public places like shopping malls, restaurants, commercial buildings, parking areas, railway stations, and airports; and government initiatives for the installation of publicly accessible charging stations. Moreover, this segment is expected to grow at the highest CAGR during the forecast period.

 

Geographically, the Asia-Pacific region accounted for the largest share of the electric vehicle charging stations market in 2020 by value as well as volume. The large share of this market is mainly attributed to the growing demand for electric vehicles in countries such as China and Japan, rising government initiatives to reduce greenhouse gas emissions, which, in turn, is poised to increase the adoption of electric vehicle and associated charging infrastructure, and ongoing investments by various countries for robust charging infrastructure used in shopping malls, public buildings, and parking facilities.

 

TOP 10 COMPANIES IN ELECTRIC VEHICLE CHARGING STATIONS MARKET

 

The key players operating in the electric vehicle charging stations market are Webasto Group (Germany), EVBox Group (Netherlands), Electrify America LLC. (U.S.), BP p.l.c. (U.K.), Royal Dutch Shell PLC (Netherlands), Evgo Services LLC. (U.S.), Connected Kerb Limited (U.K.), Wanbang Xingxing Charging Technology Co., Ltd. (China), Électricité de France (France), Tesla, Inc. (U.S.), Hangzhou Aoneng Power Supply Equipment Co., Ltd. (China), EV Charging Installers of America LLC (U.S.), Addénergie Technologies, Inc. (Canada), EV Connect, Inc. (U.S.), and ChargePoint Holdings, Inc. (U.S.).

 

Key Questions Answered in the Report-

 

Which are the high-growth market segments in terms of charging type, connection type, vehicle type, mounting type, component, end user, and geography?

What is the historical market size for electric vehicle charging stations across the globe?

What are the market forecasts and estimates for the period 2021-2028?

What are the major drivers, restraints, opportunities, and challenges in the electric vehicle charging stations market?

Who are the major players in the market, and what are their market shares?

Who are the major players in various countries, and what are their market shares?

How is the competitive landscape for the electric vehicle charging stations market?

What are the recent developments in the electric vehicle charging stations market?

What are the different strategies adopted by the major players in the market?

What are the key geographic trends, and which are the high-growth countries?

Who are the local emerging players in the electric vehicle charging stations market, and how do they compete with other players?

 

Download Free Sample Report @ https://www.meticulousresearch.com/download-sample-report/cp_id=5078?utm_source=Article&utm_medium=Social&utm_campaign=Product&utm_content=10-02-2022

 

Meticulous Research®

Email- sales@meticulousresearch.com

Contact Sales- +1-646-781-8004

Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research

Biopesticides: Share, Size and Industry Analysis

 

The North American Free Trade Agreement (NAFTA) countries (the U.S., Canada, and Mexico) are the world’s major consumers of biopesticides and use up approximately 45% of all the globally sold biopesticides, while the European Union uses 20%. In the U.S., Environmental Protection Agency (EPA) encourages the development and use of biopesticides. The Biopesticides and Pollution Prevention Division (under the Pesticide Programs) was established to facilitate the registration of biopesticides. Since biopesticides tend to pose fewer risks than chemical pesticides, EPA generally requires much fewer data to register a biopesticide than to register a conventional pesticide. Data about the composition, toxicity, degradation, and other characteristics of the pesticides are required to be submitted by the registrants to EPA to make sure that a pesticide is safe. Often less than a year is required to register a new biopesticide, compared with more than three years for a chemical pesticide.

As demands in Canada for reduced pesticide use increased, the government created new regulations and management practices. Research has identified new biopesticides, and teams have accelerated their expansion. These factors together have spurred a biopesticide revolution in Canada.

Other countries worldwide also are enacting similar changes in their political and public views toward biopesticides and investment in research. The difference is that Canada has capitalized on discovering the solution to decrease pesticides and has approved biopesticides as a reliable and peaceful replacement strategy. Canada thus provides a nice example for other countries to follow in the future

Also, in the European Union (EU), recent legislation has synchronized with the political will to reduce traditional chemical usage in agriculture and increase biopesticides. The European ban on neonicotinoid pesticides from 2013 to 2019 is driving many of the region’s growers to seek biopesticide alternatives for protecting their crops. According to Biopesticides Industry Alliance (BPIA), France, Denmark, and Sweden have aggressively reduced overall agriculture chemical use by more than 30%. The French government launched the “EcoPhyto Plan” in 2008 to reduce pesticides and plant protection products in France by 50% till 2018.

In India, several government agencies such as the Ministry of Agriculture and Farmers Welfare, the Department of Biotechnology (DBT), and the Ministry of Science and Technology have been promoting research, development, and commercialization of biopesticides and biofertilizers. The Government of India is giving a strong push to organic farming by providing subsidies for new biofertilizer/ biopesticide units. The central government of India provides grants in aid of INR 4.5 million for building and INR 2 million for procuring equipment of biocontrol laboratories for the production of biocontrol agents, including biopesticides, to state governments. It also provides around INR 2 million for procuring equipment for biopesticides testing laboratories. The requirement for registration of biopesticides has been simplified to facilitate the introduction of biopesticides.

China has also realized that the use of pesticides has created many problems. It has launched a new action plan, “Zero Growth on Chemical Fertilizer and Pesticides by 2020,” to reduce pesticides and fertilizers. China has also started a collaborative effort with the U.S. EPA on pollution issues, and one outcome of this was adapting registration procedures to favor biopesticides.

Download Research PDF @ https://www.meticulousresearch.com/download-sample-report/cp_id=5051?utm_source=FreePR&utm_medium=Social&utm_campaign=Product&utm_content=10-03-2022

Thus, recognizing the ill effects of chemical pesticides such as the development of pest resistance, pest resurgence, the outbreak of secondary pests, pesticide residues in food, feed, fodder, soil, air, and water resulting in human health hazards and ecological imbalances; most of the countries throughout the world have amended their policies to minimize the use of chemical pesticides and promote the use of the biopesticides. Such a positive role of governments drives the growth of the biopesticides market across the globe.

According to this latest publication from Meticulous Research®, the global biopesticides market is expected to grow at a CAGR of 11.7% from 2021 to 2028 to reach $9.6 billion by 2028. Also, in terms of volume, the biopesticides market is expected to record a CAGR of 9.6% from 2021 to 2028 to reach 558.4 KT by 2028.

The key players profiled in the global biopesticides market research report are Bayer AG (Germany), Marrone Bio Innovations, Inc. (U.S.), Certis USA L.L.C. (A Part of Mitsui & Co.) (U.S.), The Dow Chemical Company (Part of Dow Inc.) (U.S.), Andermatt Biocontol AG (Switzerland), BASF SE (Germany), Som Phytopharma India Limited (India), Syngenta AG (Part of ChemChina) (Switzerland), International Panaacea Ltd (IPL)(India), The Stockton (STK) Group (Israel), BioWorks, Inc. (U.S.), Novozymes A/S (Denmark), Koppert B.V. (Netherlands), W. Neudorff GmbH KG (Germany), InVivo Group (France), Valent U.S.A. LLC (part of Sumitomo Chemical Co., Ltd.) (U.S.), FMC Corporation (U.S.), and Gowan Company, LLC. (U.S.), among others.

TOP 10 COMPANIES IN BIOPESTICIDES MARKET

Scope of the Report

Biopesticides Market, by Type

• Bioinsecticide
• Biofungicide
• Bionematicide
• Bioherbicide
• Other Biopesticides

Biopesticides Market, by Origin

• Microbial
• Biochemical
• Plant Incorporated Protectant

Biopesticides Market, by Formulation

• Liquid Biopesticides
• Dry Biopesticides

Biopesticides Market, by Mode of Application

• Foliar Spray
• Seed Treatment
• Soil Treatment
• Post-Harvest
• Root Treatment
• Other Modes of Application

Biopesticides Market, by Crop Type

• Fruits & Vegetables
• Cereals & Grains
• Oilseeds & Pulses
• Other Crops

Biopesticides Market, by Geography

• North America

o U.S.

o Canada

• Europe

o Spain

o France

o Germany

o Italy

o U.K.

o Rest of Europe

• Asia-Pacific

o China

o India

o Australia

o Japan

o Rest of Asia-Pacific

• Latin America

o Brazil

o Mexico

o Argentina

o Chile

o Rest of Latin America

• Middle East & Africa

Request Sample PDF Broachers @ https://www.meticulousresearch.com/request-sample-report/cp_id=5051?utm_source=FreePR&utm_medium=Social&utm_campaign=Product&utm_content=10-03-2022